Header Logo

Connection

Richard Pietras to Female

Back to Details
This is a "connection" page, showing publications Richard Pietras has written about Female.
Richard Pietras
Connection Strength
1.629
Female
  1. Manuka Honey Inhibits Human Breast Cancer Progression in Preclinical Models. Nutrients. 2024 Jul 22; 16(14).
    View in: PubMed
    Score: 0.132
  2. Progesterone Receptor Signaling in the Breast Tumor Microenvironment. Adv Exp Med Biol. 2021; 1329:443-474.
    View in: PubMed
    Score: 0.103
  3. Antiestrogens in combination with immune checkpoint inhibitors in breast cancer immunotherapy. J Steroid Biochem Mol Biol. 2019 10; 193:105415.
    View in: PubMed
    Score: 0.093
  4. Squalamine blocks tumor-associated angiogenesis and growth of human breast cancer cells with or without HER-2/neu overexpression. Cancer Lett. 2019 05 01; 449:66-75.
    View in: PubMed
    Score: 0.091
  5. Randomized phase II study of fulvestrant and erlotinib compared with erlotinib alone in patients with advanced or metastatic non-small cell lung cancer. Lung Cancer. 2018 09; 123:91-98.
    View in: PubMed
    Score: 0.087
  6. Extranuclear signaling by sex steroid receptors and clinical implications in breast cancer. Mol Cell Endocrinol. 2018 05 05; 466:51-72.
    View in: PubMed
    Score: 0.083
  7. Receptors for Insulin-Like Growth Factor-2 and Androgens as Therapeutic Targets in Triple-Negative Breast Cancer. Int J Mol Sci. 2017 Nov 02; 18(11).
    View in: PubMed
    Score: 0.083
  8. Biologic roles of estrogen receptor-ß and insulin-like growth factor-2 in triple-negative breast cancer. Biomed Res Int. 2015; 2015:925703.
    View in: PubMed
    Score: 0.069
  9. Estrogen Receptor-ß and the Insulin-Like Growth Factor Axis as Potential Therapeutic Targets for Triple-Negative Breast Cancer. Crit Rev Oncog. 2015; 20(5-6):373-90.
    View in: PubMed
    Score: 0.068
  10. Progesterone and estrogen receptor expression and activity in human non-small cell lung cancer. Steroids. 2011 Aug; 76(9):910-20.
    View in: PubMed
    Score: 0.053
  11. Rational management of endocrine resistance in breast cancer: a comprehensive review of estrogen receptor biology, treatment options, and future directions. Cancer. 2008 Nov 01; 113(9):2385-97.
    View in: PubMed
    Score: 0.044
  12. Estrogen receptors outside the nucleus in breast cancer. Breast Cancer Res Treat. 2008 Apr; 108(3):351-61.
    View in: PubMed
    Score: 0.040
  13. Estrogen receptors in membrane lipid rafts and signal transduction in breast cancer. Mol Cell Endocrinol. 2006 Feb 26; 246(1-2):91-100.
    View in: PubMed
    Score: 0.037
  14. Aromatase inhibitors in human lung cancer therapy. Cancer Res. 2005 Dec 15; 65(24):11287-91.
    View in: PubMed
    Score: 0.036
  15. Estrogen receptors and cell signaling. Science. 2005 Oct 07; 310(5745):51-3; author reply 51-3.
    View in: PubMed
    Score: 0.036
  16. New approaches to reverse resistance to hormonal therapy in human breast cancer. Drug Resist Updat. 2005 Aug; 8(4):219-33.
    View in: PubMed
    Score: 0.035
  17. Biological characteristics of the pure antiestrogen fulvestrant: overcoming endocrine resistance. Breast Cancer Res Treat. 2005; 93 Suppl 1:S11-8.
    View in: PubMed
    Score: 0.034
  18. Interactions between estrogen and growth factor receptors in human breast cancers and the tumor-associated vasculature. Breast J. 2003 Sep-Oct; 9(5):361-73.
    View in: PubMed
    Score: 0.031
  19. Sex steroid hormones and DNA repair regulation: Implications on cancer treatment responses. J Steroid Biochem Mol Biol. 2023 03; 227:106230.
    View in: PubMed
    Score: 0.029
  20. Squalamine and cisplatin block angiogenesis and growth of human ovarian cancer cells with or without HER-2 gene overexpression. Oncogene. 2002 Apr 25; 21(18):2805-14.
    View in: PubMed
    Score: 0.028
  21. Epidermal growth factor receptor and tyrosine phosphorylation of estrogen receptor. Endocrine. 2001 Nov; 16(2):73-81.
    View in: PubMed
    Score: 0.027
  22. Membrane-associated binding sites for estrogen contribute to growth regulation of human breast cancer cells. Oncogene. 2001 Sep 06; 20(39):5420-30.
    View in: PubMed
    Score: 0.027
  23. Steroid hormone receptors in target cell membranes. Endocrine. 2001 Apr; 14(3):417-27.
    View in: PubMed
    Score: 0.026
  24. Cell membrane estrogen receptors resurface. Nat Med. 1999 Dec; 5(12):1330.
    View in: PubMed
    Score: 0.024
  25. Monoclonal antibody to HER-2/neureceptor modulates repair of radiation-induced DNA damage and enhances radiosensitivity of human breast cancer cells overexpressing this oncogene. Cancer Res. 1999 Mar 15; 59(6):1347-55.
    View in: PubMed
    Score: 0.023
  26. Remission of human breast cancer xenografts on therapy with humanized monoclonal antibody to HER-2 receptor and DNA-reactive drugs. Oncogene. 1998 Oct 29; 17(17):2235-49.
    View in: PubMed
    Score: 0.022
  27. CD24 Expression and differential resistance to chemotherapy in triple-negative breast cancer. Oncotarget. 2017 Jun 13; 8(24):38294-38308.
    View in: PubMed
    Score: 0.020
  28. A83-01 inhibits TGF-ß-induced upregulation of Wnt3 and epithelial to mesenchymal transition in HER2-overexpressing breast cancer cells. Breast Cancer Res Treat. 2017 Jun; 163(3):449-460.
    View in: PubMed
    Score: 0.020
  29. Possible failure of novel direct-acting oral anticoagulants in management of pulmonary embolism: a case report. J Med Case Rep. 2016 Dec 03; 10(1):346.
    View in: PubMed
    Score: 0.019
  30. Progesterone receptor (PR) polyproline domain (PPD) mediates inhibition of epidermal growth factor receptor (EGFR) signaling in non-small cell lung cancer cells. Cancer Lett. 2016 May 01; 374(2):279-91.
    View in: PubMed
    Score: 0.018
  31. Ribonucleotide reductase subunit M2 predicts survival in subgroups of patients with non-small cell lung carcinoma: effects of gender and smoking status. PLoS One. 2015; 10(5):e0127600.
    View in: PubMed
    Score: 0.017
  32. Antibody to HER-2/neu receptor blocks DNA repair after cisplatin in human breast and ovarian cancer cells. Oncogene. 1994 Jul; 9(7):1829-38.
    View in: PubMed
    Score: 0.016
  33. Expression levels of estrogen receptor beta in conjunction with aromatase predict survival in non-small cell lung cancer. Lung Cancer. 2011 Nov; 74(2):318-25.
    View in: PubMed
    Score: 0.013
  34. Aromatase expression predicts survival in women with early-stage non small cell lung cancer. Cancer Res. 2007 Nov 01; 67(21):10484-90.
    View in: PubMed
    Score: 0.010
  35. The combination of green tea and tamoxifen is effective against breast cancer. Carcinogenesis. 2006 Dec; 27(12):2424-33.
    View in: PubMed
    Score: 0.009
  36. Usefulness of 3'-[F-18]fluoro-3'-deoxythymidine with positron emission tomography in predicting breast cancer response to therapy. Mol Imaging Biol. 2006 Jan-Feb; 8(1):36-42.
    View in: PubMed
    Score: 0.009
  37. Targeted therapy: wave of the future. J Clin Oncol. 2005 Mar 10; 23(8):1776-81.
    View in: PubMed
    Score: 0.009
  38. Specific internalization of estrogen and binding to nuclear matrix in isolated uterine cells. Biochem Biophys Res Commun. 1984 Aug 30; 123(1):84-91.
    View in: PubMed
    Score: 0.008
  39. Rational combinations of trastuzumab with chemotherapeutic drugs used in the treatment of breast cancer. J Natl Cancer Inst. 2004 May 19; 96(10):739-49.
    View in: PubMed
    Score: 0.008
  40. Immunologic inhibition of estrogen binding and action in preputial-gland cells and their subcellular fractions. J Steroid Biochem. 1981 Aug; 14(8):679-91.
    View in: PubMed
    Score: 0.007
  41. Lysosomal cathepsin B-like activity: mobilization in prereplicative and neoplastic epithelial cells. J Histochem Cytochem. 1981 Mar; 29(3A Suppl):440-50.
    View in: PubMed
    Score: 0.007
  42. Partial purification and characterization of oestrogen receptors in subfractions of hepatocyte plasma membranes. Biochem J. 1980 Dec 01; 191(3):743-60.
    View in: PubMed
    Score: 0.006
  43. Biologic effects of heregulin/neu differentiation factor on normal and malignant human breast and ovarian epithelial cells. Oncogene. 1999 Oct 28; 18(44):6050-62.
    View in: PubMed
    Score: 0.006
  44. Estrogen receptors in uterine plasma membrane. J Steroid Biochem. 1979 Oct; 11(4):1471-83.
    View in: PubMed
    Score: 0.006
  45. Estrogen-induced membrane alterations and growth associated with proteinase activity in endometrial cells. J Cell Biol. 1979 Jun; 81(3):649-63.
    View in: PubMed
    Score: 0.006
  46. Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers. Oncogene. 1999 Apr 01; 18(13):2241-51.
    View in: PubMed
    Score: 0.006
  47. Elevated serum cathepsin B1-like activity in women with neoplastic disease. Gynecol Oncol. 1979 Feb; 7(1):1-17.
    View in: PubMed
    Score: 0.006
  48. Metabolic and proliferative responses to estrogen by hepatocytes selected for plasma membrane binding-sites specific for estradiol-17beta. J Cell Physiol. 1979 Jan; 98(1):145-59.
    View in: PubMed
    Score: 0.006
  49. Elevated serum cathepsin B1 and vaginal pathology after prenatal DES exposure. Obstet Gynecol. 1978 Sep; 52(3):321-7.
    View in: PubMed
    Score: 0.005
  50. The effect of HER-2/neu overexpression on chemotherapeutic drug sensitivity in human breast and ovarian cancer cells. Oncogene. 1997 Jul 31; 15(5):537-47.
    View in: PubMed
    Score: 0.005
  51. Specific binding sites for oestrogen at the outer surfaces of isolated endometrial cells. Nature. 1977 Jan 06; 265(5589):69-72.
    View in: PubMed
    Score: 0.005
  52. Surface modifications evoked by estradiol and diethylstilbestrol in isolated endometrial cells: evidence from lectin probes and extracellular release of lysosomal protease. Endocrinology. 1975 Dec; 97(6):1445-54.
    View in: PubMed
    Score: 0.005
  53. Steroid hormone-responsive, isolated endometrial cells. Endocrinology. 1975 Apr; 96(4):946-54.
    View in: PubMed
    Score: 0.004
  54. Endometrial cell calcium and oestrogen action. Nature. 1975 Jan 31; 253(5490):357-9.
    View in: PubMed
    Score: 0.004
  55. Hormonal influences on odor detection in rats: changes associated with the estrous cycle, pseudopregnancy, ovariectomy, and administration of testosterone propionate. Physiol Behav. 1974 Mar; 12(3):475-91.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.